Sign in Pull a receipt

RNTX

Rein Therapeutics, Inc.

Healthcare · Biotechnology

$277.44 sample

+0.68 (+0.25%) 1D

Market cap

$961.3B

Price as of

2026-10-29

Latest filing

8-K · 2026-09-14

Alerts

8

Price$277.44 +3.08% 3M daily closessample

283.62260.71

2026-08-032026-08-252026-09-162026-10-072026-10-29

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 26INSInsider sell: 10% owner
Oct 16INSInsider buy: 10% owner
Oct 07INSInsider buy: General Counsel
Sep 30INSInsider sell: EVP, Operations
Sep 25INSInsider sell: Director
Sep 18INSInsider buy: 10% owner
Sep 14SECDEF 14A filed
Sep 03SEC8-K filed: material event

Sign up to see the real RNTX record →

Company facts

SEC EDGAR registration

Name: Rein Therapeutics, Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: +36sample, -100 to +100
Reporting currency: USD

Who is positioning in RNTX

sample

Insiders: 17 insider transactions over 90 days, net selling, $460.9M
Congress: 2 members traded over 90 days
Institutions · 13F: 9 funds hold $16.9B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$42.5B +15.3% y/y

Q4 2024Q3 2026

Inventory$26.4B +14.8% y/y

Q4 2024Q3 2026

Accounts receivable$19.7B +10.8% y/y

Q4 2024Q3 2026

Total debt$49.7B +8.7% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $898.9B +2.0% 3M
Sample peer B: $942.8B -8.3% 3M
Sample peer C: $529.5B -1.0% 3M
Sample peer D: $659.5B -3.2% 3M
Sample peer E: $176.8B +12.8% 3M